1. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. Issue 2 (10th August 2016) Authors: Betti, M.; Aspesi, A.; Biasi, A.; Casalone, E.; Ferrante, D.; Ogliara, P.; Gironi, L.C.; Giorgione, R.; Farinelli, P.; Grosso, F.; Libener, R.; Rosato, S.; Turchetti, D.; Maffè, A.; Casadio, C.; Ascoli, V.; Dianzani, C.; Colombo, E.; Piccolini, E.; Pavesi, M. Journal: Cancer letters Issue: Volume 378:Issue 2(2016) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetic study of trabectedin administered as 24-hour infusion in elderly patients with advanced soft tissue sarcoma (STS) treated according to the TR1US ISG study. (December 2016) Authors: Ferrari, M.; Grosso, F.; Grignani, G.; Ibrahim, T.; Tamberi, S.; Marra, D.; Marchesi, E.; Porcu, L.; D'Incalci, M.; Zucchetti, M. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗